NetEase.com (NTES) PT Lowered to $120 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts NTES Hot Sheet
Price: $121.26 +4.33%
Rating Summary:
28 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 13
Rating Summary:
28 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst Alex Poon lowered the price target on NetEase.com (NASDAQ: NTES) to $120.00 (from $130.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Pfizer (PFE) PT Raised to $40 at Argus
- Zimmer Biomet (ZBH) PT Raised to $120 at Jefferies
- Wayfair (W) PT Raised to $160 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
